Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon

被引:44
作者
Wolff, MC [1 ]
Leander, JD [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
SSRI; 5-HT1A agonist; 5-HT1A antagonist; impulsive behavior; pigeon;
D O I
10.1016/S0893-133X(02)00307-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The inability to delay gratification (reinforcement or reward) is one index of impulsive behavior. In order to measure the willingness of pigeons to delay reinforcement, an adjustable delay schedule was developed that allowed daily approximations of an indifference point between immediate brief access to reinforcer and delayed, longer access to reinforcer. Acute administration of the anxiolytic alprazolam (5 mg/kg) decreased the length of delay tolerated before a larger reinforcement. Likewise, acute administration of the anxiolytic chlordiazepoxide (10 mg/ kg) produced a similar, although not significant, effect. Neither acute nor five daily injections of 8-OH-DPAT, a 5-HT1A agonist, or WAY100635, a 5-HT1A antagonist, affected the length of the delay period. Chronic (17 day), but not acute injections of the selective serotonin reuptake inhibitors (SSRIs)fluoxetine (10 mg/kg), citalopram (10 mg/kg) and paroxetine (3 mg/kg) increased the delay period. When given in addition to 1 mg/kg of 8-OH-DPAT, but not 1 mg/kg WAY100635, the effect of fluoxetine was accelerated in that the increase in delay was observed earlier in the treatment. These data support the use of SSRIs to decrease impulsive behavior. Addition of a 5-HT1A agonist, but not a 5-HT1A antagonist, to the SSRI may hasten the therapeutic activity of the SSRI in treating impulsivity. (C) 2002 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:421 / 429
页数:9
相关论文
共 31 条
[1]  
AINSLIE GW, 1974, J EXP ANAL BEHAV, V21, P481
[2]  
ARTIGAS F, 1994, ARCH GEN PSYCHIAT, V51, P248
[3]   Serotonin and tolerance to delay of reward in rats [J].
Bizot, JC ;
Le Bihan, C ;
Puech, AJ ;
Hamon, M ;
Thiébot, MH .
PSYCHOPHARMACOLOGY, 1999, 146 (04) :400-412
[4]  
BIZOT JC, 1988, J PHARMACOL EXP THER, V246, P1144
[5]  
BLIER P, 1983, J NEUROSCI, V3, P1270
[6]   EFFECTIVENESS OF PINDOLOL WITH SELECTED ANTIDEPRESSANT DRUGS IN THE TREATMENT OF MAJOR DEPRESSION [J].
BLIER, P ;
BERGERON, R .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (03) :217-222
[7]   Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice [J].
Brunner, D ;
Hen, R .
NEUROBIOLOGY OF SUICIDE: FROM THE BENCH TO THE CLINIC, 1997, 836 :81-105
[8]   Effects of psychotropic drugs on rat responding in an operant paradigm involving choice between delayed reinforcers [J].
Charrier, D ;
Thiebot, MH .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 54 (01) :149-157
[9]   Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo [J].
Clifford, EM ;
Gartside, SE ;
Umbers, V ;
Cowen, PJ ;
Hajós, M ;
Sharp, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (01) :206-212
[10]  
DEVRY J, 1995, PSYCHOPHARMACOLOGY, V121, P1